Comprehensive Review of Integration of Artificial Intelligence in Pharmacogenomics for Personalized Medicine
International Journal of Pharmaceutical Sciences Review and Research · 2026-06 · 86 (6)
DOI: 10.47583/ijpsrr.2026.v86i6.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Sciences Review and Research, 2026-06. Verfasst von Sonali T Kolekar und 8 weiteren Autor:innen.
Abstract (Originalsprache)
The convergence of artificial intelligence (AI) and pharmacogenomics represents a transformative paradigm in contemporary medicine.Pharmacogenomics investigates the relationship between individual genetic variations and drug response, whereas AI provides computational frameworks capable of discerning complex patterns within high-dimensional biological datasets.This review comprehensively examines the integration of AI methodologies including machine learning, deep learning, and natural language processing into pharmacogenomic research and clinical practice, with an emphasis on personalized medicine.The applications of AI span the entire continuum of drug development: from target identification and compound discovery to preclinical prediction, clinical trial optimization, real-world data mining, pharmacokinetic modelling, and pharmacogenomics-driven dose individualization.Multimodal data integration platforms that combine clinical, laboratory, imaging, -omics, wearable device, and environmental data are discussed as essential infrastructure supporting AI-driven decisions.Furthermore, the role of AI in next-generation sequencing (NGS) interpretation, gene functionality scoring, and therapeutic area-specific genetic guidance is elaborated.While promising, the implementation of AI in pharmacogenomics is accompanied by substantial challenges relating to data quality, algorithmic bias, regulatory compliance, and ethical considerations.The review also presents a future outlook wherein AI and precision medicine collaboratively enhance individualized healthcare across clinical, social, and genomic dimensions.A structured synthesis of 55 peerreviewed references is provided to guide future research directions.
Zitieren
APA
Kolekar, S. T., Devade, O. A., Jadhav, P. D., Pawar, N. S., Potdar, G. S., Mohite, N. C., Shaikh, R. M., Dalavi, C. S., & Bhosale, V. V. (2026). Comprehensive Review of Integration of Artificial Intelligence in Pharmacogenomics for Personalized Medicine. International Journal of Pharmaceutical Sciences Review and Research, 86(6). https://doi.org/10.47583/ijpsrr.2026.v86i6.010
Vancouver
Kolekar ST, Devade OA, Jadhav PD, Pawar NS, Potdar GS, Mohite NC, et al. Comprehensive Review of Integration of Artificial Intelligence in Pharmacogenomics for Personalized Medicine. International Journal of Pharmaceutical Sciences Review and Research. 2026;86(6). doi:10.47583/ijpsrr.2026.v86i6.010
BibTeX
@article{Kolekar2026,
author = {Kolekar, Sonali T and Devade, Omkar A and Jadhav, Prakash D and Pawar, Neha S and Potdar, Gaurav S and Mohite, Nikita C and Shaikh, Rahim M and Dalavi, Chaitali S and Bhosale, Vaishnavi V},
title = {Comprehensive Review of Integration of Artificial Intelligence in Pharmacogenomics for Personalized Medicine},
journal = {International Journal of Pharmaceutical Sciences Review and Research},
year = {2026},
volume = {86},
number = {6},
doi = {10.47583/ijpsrr.2026.v86i6.010}
}
EUVIMED